Professor of Surgery, Washington University St Louis
General Surgery
Dr. Jeffrey F. Moley, MD
|
|
Give Review
Jeffrey F. Moley practices General Surgery. He researched medicine at Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is a top medical university. Columbia University College of Physicians & Surgeons is ranked 8 in research and 52 in primary care medicine He received awards:"America's Top Doctors", "America's Top Doctors for Cancer", "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Doctor Jeffrey F. Moley, MD is a published MD as well. He has 95 publications published. The latest was: Medullary thyroid carcinoma: genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia. He accepts all Medicare patients.
Publications
- Surgery for lymph node metastases of medullary thyroid Carcinoma: A review.
- Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma The American Thyroid Association Guidelines Task Force on Medullary T...
- BRAF mutation is not predictive of long-term outcome in papillary thyroid Carcinoma.
- Hereditary thyroid Cancer syndromes and genetic testing.
- Thyroid Carcinoma, version 2.2014.
- Biochemical Cure after Reoperations for Medullary Thyroid Carcinoma: A Meta-Analysis.
- Treatment Approach, Surveillance and Outcome of Well-differentiated Thyroid Cancer in Childhood and Adolescence.
- Adrenal myelolipoma: operative indications and outcomes.
- Pheochromocytoma in an 8-year-old patient with multiple endocrine neoplasia type 2A: Implications for screening.
- Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid Carcinoma.
- Risk factors affecting operative approach, conversion, and morbidity for Adrenalectomy: a single-institution series of 402 patients.
- A novel missense mutation in the MEN1 gene in a patient with multiple endocrine neoplasia type 1.
- Management of cervical nodal metastasis detected on I-131 scintigraphy after initial surgery of well-differentiated thyroid Carcinoma.
- Medullary, anaplastic, and metastatic Cancers of the thyroid.
- The role of surgery in Cancer prevention.
- Exclusion of malignancy in Thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: inter...
- Phase II clinical trial of sorafenib in metastatic medullary thyroid Cancer.
- The RET Protooncogene.
- Multiple endocrine neoplasia type 2: clinical manifestations and management.
- Sporadic and familial medullary thyroid Carcinoma: state of the art.
- Prognostic factors in patients with well-differentiated thyroid Cancer presenting with pulmonary metastasis.
- Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid Cancer.
- RET proto-oncogene testing in infants presenting with Hirschsprung Disease identifies 2 new multiple endocrine neoplasia 2A kindreds.
- Ultrasound facilitates minimally invasive Parathyroidectomy in patients lacking definitive localization from preoperative sestamibi scan.
- Pheochromocytoma penetrance varies by RET mutation in MEN 2A.
- Needle biopsy of incidentally discovered Adrenal masses is rarely informative and potentially hazardous.
- Evidence-based approach to the management of sporadic medullary thyroid Carcinoma.
- Current approaches to medullary thyroid Carcinoma, sporadic and familial.
- Contralateral papillary thyroid Cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment.
- Lymph node metastases in differentiated thyroid Cancer under 2 cm.
- ASCO/SSO review of current role of risk-reducing surgery in common hereditary Cancer syndromes.
- Long-term functionality of cryopreserved parathyroid autografts: a 13-year prospective Analysis.
- Outpatient minimally invasive parathyroidectomy using local/Regional anesthesia: a safe and effective operative approach for selected patients.
- Adrenal ganglioneuromas in children with multiple endocrine neoplasia type 2: a report of two cases.
- Medullary thyroid Cancer: medical management and follow-up.
- Medullary thyroid Carcinoma: management of lymph node metastases.
- Medullary thyroid Carcinoma: including MEN 2A and MEN 2B syndromes.
- Hereditary medullary thyroid Carcinoma in patients greater than 50 years old.
- Expression profiles provide insights into early malignant potential and skeletal abnormalities in multiple endocrine neoplasia type 2B syndrome Tumors.
- Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking.
- Preparation of patients with thyroid Cancer for 131I scintigraphy or therapy by 1-3 weeks of thyroxine discontinuation.
- Sentinel lymph node biopsy in patients with thin melanoma.
- Inhibition of medullary thyroid Carcinoma cell proliferation and RET phosphorylation by tyrosine kinase inhibitors.
- GastroIntestinal manifestations of multiple endocrine neoplasia type 2.
- Adrenalectomy for familial pheochromocytoma in the laparoscopic era.
- Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators.
- Invited commentary: Are specific inherited mutations important in clinical management of hereditary Cancer syndromes?
- Long-term outcome of reoperations for medullary thyroid Carcinoma.
- Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid Cancer.
- Racial differences in survival after surgical treatment for melanoma.
- Neuroblastoma. Effect of genetic factors on prognosis and treatment.
- [Re-education techniques in an intitutinal milieu].
- A comparison of surface antigens of senescent and presenescent human fibroblasts.
- Diabetes and Abdominal surgery: the mutual risks.
- Alternative to retroperitoneal lymphadenectomy with preservation of ejaculation and fertility in stage I nonseminomatous testicular Cancer. A prospective study.
- Medullary thyroid Cancer: management guidelines of the American Thyroid Association.
- Metastatic disease to the Breast: the Washington University experience.
- Allelic imbalance of the mutant and wild-type RET allele in MEN 2A-associated medullary thyroid Carcinoma.
- Risk of malignancy in Thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography.
- Outcomes analysis in patients undergoing laparoscopic Adrenalectomy for hormonally active Adrenal tumors.
- Evaluation of the performance and clinical impact of a rapid intraoperative Parathyroid hormone assay in conjunction with preoperative imaging and concise Parathyroide...
- Strategy for identification of novel glucose transporter family members by using internet-based genomic databases.
- Thyroid Cancer: 1999 update.
- Cloning and expression Analysis of a novel member of the facilitative glucose transporter family, SLC2A9 (GLUT9).
- Soft-tissue sarcomas.
- Multiple endocrine neoplasias.
- Laparoscopic ultrasound imaging of Adrenal tumors during laparoscopic Adrenalectomy.
- Four new mutations in the DNA mismatch repair gene MLH1 in colorectal Cancers with microsatellite instability. Mutations in brief no. 157. Online.
- Brain metastases from medullary thyroid Carcinoma in a patient with multiple endocrine neoplasia type 2A.
- Preservation of the recurrent laryngeal nerves in thyroid and Parathyroid reoperations.
- Hereditary endocrinopathies.
- Compartment-mediated dissection for papillary thyroid Cancer.
- Patterns of nodal metastases in palpable medullary thyroid Carcinoma: recommendations for extent of node dissection.
- Medullary thyroid Carcinoma: genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia.
- Surgical management of patients with persistent or recurrent medullary thyroid Cancer.
- Confirmation that chromosome 18q allelic loss in colon Cancer is a prognostic indicator.
- Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid Carcinoma and pheo...
- Absence of TP53 alterations in pheochromocytomas and medullary thyroid Carcinomas.
- "Cold" single-strand conformational variants for mutation Analysis of the RET protooncogene.
- Prognostic value of chromosome 1p allelic loss in colon Cancer.
- Improved results of cervical reoperation for medullary thyroid Carcinoma.
- Differential display in primary and metastatic medullary thyroid Carcinoma.
- Heterotopic autotransplantation of Parathyroid tissue in children undergoing total thyroidectomy.
- The molecular genetics of multiple endocrine neoplasia type 2A and related syndromes.
- Laparoscopic Adrenalectomy compared to open Adrenalectomy for benign Adrenal neoplasms.
- Medullary thyroid Carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
- Reoperation for recurrent or persistent medullary thyroid Cancer.
- Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.
- Predictive DNA testing and prophylactic Thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A.
- Loss of neurofibromatosis type I (NF1) gene expression in pheochromocytomas from patients without NF1.
- Laparoscopic detection of hepatic metastases in patients with residual or recurrent medullary thyroid Cancer.
- Insulin reversal of Cancer cachexia in rats.
- Parabiotic transfer of Cancer anorexia/cachexia in male rats.
- Preoperative insulin reverses cachexia and decreases mortality in Tumor-bearing rats.
Schools
Columbia University College of Physicians And Surgeons
Yale University
Procedures Preformed
- Adrenalectomy
- Biopsy of Breast
- Colectomy
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- View All
Conditions Treated
- Abdominal Pain
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Atelectasis
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
Yale New Haven Children's Center -
National Institutes of Health Clinical Center -
Yale-New Haven Hospital -
Columbia University College of Physicians & Surgeons
Hospital
-
Barnes-Jewish Hospital -
St. Louis Children's Hospital
Drug Facts
| NPI NUMBER | 1124044433 | |
| NPPES Provider LastName | MOLEY | |
| NPPES Provider FirstName | JEFFREY | |
| NPPES Provider ZIPCode | 631101026 | |
| NPPES Provider State | MO | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 53.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1124044433 |
| Last Name Of The Provider | MOLEY |
| First Name Of The Provider | JEFFREY |
| View All |
Similar Doctors
|
|
Dr. David C. Linehan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert E. Schlitt, MD |
|
Dr. Joseph J. Hurley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roger V. Vardeleon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald J. Gaskin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cornell T. Cummings, MD |
|
|
Dr. Corey N. Ming-Lum, MD |
|
|
Dr. Enjae Jung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew S. Strand, MD |
|
|
Dr. Jack Simons, DO |
|
|
Dr. Andrew J. Smith, MD |